Back to catalogue
№ 090 32 filings · 2021-08-06 → 2026-08-05

CAKE BOX HOLDINGS PLC

CBOX
Personal Care, Drug and Grocery Stores Share price 193p Market cap £85m Overall fit 300 /1000

Decent quality franchise cake retailer at a fair-to-cheap valuation with acceptable downside protection, but with essentially zero AI-receiver exposure and only moderate operating leverage — fails the investor's primary AI and long-tail-upside criteria despite reasonable standalone attractiveness.

Fair value range 200p–240p Mid case · £97m
Absolute upside +14.3% vs current market cap
Conviction 3/5 confidence in undervalued call
Supports the call
  • unqualified audit and clear segmental disclosure post-Ambala
  • consistent multi-year FCF and dividend growth
  • freehold-backed balance sheet with 0.88x leverage
Limits the call
  • repeated intangible impairments and prior-period restatements
  • Ambala synergy delivery still to be proven
Methodology

Forward P/E cross-checked with EV/EBITDA and FCF yield

In one line · bull case

Cash-generative UK franchised cake retailer at ~11.6x earnings with 5.8% yield, expanding estate and integrating Ambala for medium-term upside.

In one line · biggest risk

Discretionary consumer spend on celebration cakes is vulnerable to macro shocks, as the 2022 profit warning demonstrated.

Drivers
AI beneficiary 8 /100
Retailer of fresh-cream cakes; no revenue, addressable market, or margin driver linked to AI adoption.
Operating leverage 55 /100
Franchisor gearing (Cake Box overheads +3% vs revenue +9.3% in FY26) is real but not SaaS-like; Ambala corporate stores dilute the mix.
Earnings vs expectations 55 /100
Mostly in-line/small-beats since 2023, but Aug 2022 profit warning is a scar in the record.
Growth momentum 65 /100
Group revenue +39.5% (Ambala) and Cake Box organic +9.3% with 25 net new stores and LFL +4.8% in FY26.
Moat 40 /100
Local brand strength and franchise network but low switching costs and easy substitutes; scale advantage building via depot network.
Earnings quality 55 /100
Underlying EBITDA solid and cash-backed, but recurring intangible impairments and prior-period restatements drag on quality.
Management quality 45 /100
Founder-led with progressive dividend and clear expansion plan; offset by ERP/website write-offs, prior CFO turnover, related-party trading and FRC-triggered restatements.
Cyclicality 45 /100
Celebration cakes are discretionary treat spend — sensitive to weather, holidays and cost-of-living squeezes as shown in 2022.
Leverage 30 /100
Net debt £10.8m / 0.88x underlying EBITDA with freehold property collateral — comfortable.
Value-trap signals · 4
  • Repeated intangible impairments on ERP/website builds (£1.65m in FY26; prior write-downs)
  • Prior-period restatements from Ambala acquisition accounting and 2024 FRC review
  • Material related-party sales to Director-connected entities (£2.3m in FY26)
  • Aug 2022 profit warning and consumer sensitivity to weather/inflation

CAKE BOX HOLDINGS PLC (CBOX) — Investment Research Note

Executive summary

Cake Box is the UK's largest retailer of fresh-cream celebration cakes, operating a capital-light franchise model (276 Cake Box + 34 Ambala stores at March 2026) with three freehold depots supplying franchisees. Trajectory has been solid: Group revenue £37.8m → £42.8m → £59.7m (FY24→26), underlying EBITDA £7.5m → £8.7m → £12.4m, with FY26 boosted by a maiden full year of Ambala (acquired Mar 2025 for £22m). The single most important point for valuation today is that the shares trade on ~11.6× underlying EPS with a ~5.8% dividend yield and 11%+ FCF yield — cheap on quality-food-franchise metrics, but with no meaningful AI angle for this investor.

Fair value estimate

  • Range: 200p – 240p per share → implied market cap £88m – £106m
  • Methodology: forward-year multiple of underlying earnings, cross-checked to EV/EBITDA and FCF yield.
    • FY26 underlying EPS 15.97p 2026-06 final results; assume FY27 underlying EPS of ~17.0–17.5p on continued 8–10% Cake Box organic growth, Ambala synergy delivery and normalised interest.
    • Apply 12–14× to forward EPS (in line with UK small-cap food-franchise peers and reflecting sub-scale AIM listing) → 204–245p.
    • Cross-check: EV/EBITDA of ~8× on FY27 EBITDA of ~£13.5m → EV ~£108m less net debt ~£10m = £98m equity, ~223p/share. FCF yield check: FCF £9.5m 2026-06 final results on 44m shares = 21.7p FCF/share; at 10% yield → 217p.
  • Comparison to £81.8m disclosed market cap (186p): mid-point fair value ~220p implies ~18% upside (range: +7% to +29%).

Sector context

  • Sector classification confirmed: Personal Care, Drug and Grocery Stores — though Cake Box is more accurately a franchised bakery/food retailer.
  • Quality/growth: broadly in line to modestly above typical UK small-cap food retail; franchise model gives above-average cash conversion, but Ambala corporate stores dilute the asset-light story.
  • Listed peers: Greggs (much larger scale, higher-quality read-across on category), Domino's Pizza UK (comparable franchise economics), and Cranswick (UK food, quality benchmark). Cake Box trades at a material discount to all three on EV/EBITDA.

Investment thesis

  • Franchise model delivering scalable, cash-generative growth: 25 net new Cake Box stores in FY26 taking the estate to 276, with 4.8% LFL and 12.4% Cake Box system sales growth on a healthy pipeline toward the 400-store target 2026-06 final results. Cake Box-only underlying EBITDA rose 21.7% as overheads grew 3.0% vs revenue growth of 9.3% — evidence of the franchisor operating gearing.
  • Balance sheet and dividend support downside: leverage 0.88× underlying EBITDA, ~£15.5m of freehold property (independently valued), FCF of £9.5m and full-year dividend up for the fifth consecutive year to 10.8p (~5.8% yield) 2026-06 final results. Downside is well-protected for a small-cap AIM name.
  • Ambala integration option value: maiden full-year revenue £14.1m and £1.85m EBITDA from Ambala with integration "largely complete" and franchising rollout ahead of plan (12 vs 10 targeted openings) 2026-06 final results. If Ambala franchising accelerates margins toward Cake Box's 22.9% underlying EBITDA margin, group EBITDA has meaningful upside beyond current forecasts.

Key risks

  • Zero AI exposure: this is a bricks-and-mortar franchised food retailer; nothing in the filings 2026-06 final results, 2025-11 half year points to AI-driven revenue, addressable-market expansion, or productivity moat that would matter for the stated strategy.
  • Consumer sensitivity and inflation: management repeatedly flags "challenging consumer environment" and inflationary pressures on input costs 2026-04 trading update, 2026-06 final results; the Aug 2022 profit warning demonstrated the fragility of like-for-like sales to weather and cost-of-living shocks.
  • Governance/accounting history and related parties: repeated IT/ERP impairments (£1.65m in FY26 alone), prior-year restatements for Ambala acquisition accounting (professional fees expensed, S.458 obligation recognised), FRC review triggered restatements in FY24, and material sales to companies controlled by Directors' close family (£1.9m to Dr Singh-related entities in FY26) 2026-06 final results. Not fatal, but a cluster of small yellow flags.

Operating leverage

Cake Box's franchisor economics show moderate-to-decent operating leverage but not the high-fixed-cost SaaS profile the investor wants. FY26 evidence: Cake Box (excluding Ambala) grew revenue 9.3% and gross profit 10.3%, while overheads rose only 3.0%, driving underlying EBITDA up 21.7% 2026-06 final results. Gross margin at group level expanded 490bps to 57.4%, though this is inflated by Ambala corporate-store mix (69.9% gross margin). The three freehold depots (Enfield, Coventry, Bradford — with a new Bradford warehouse being built at £2.6m capex) create real operational gearing: incremental franchise volumes flow through relatively fixed depot cost bases. A plausible 10–15% revenue upside to plan could translate into 20–30% upside to EBITDA on the Cake Box segment — meaningful but not multiples-of-profit, so ~55/100 on the operating-leverage scale. Ambala's corporate stores (101 store staff) dilute this leverage on the group basis.

Value-trap signals

  • Repeated intangible-asset impairments (bespoke ERP, previous website, omni-channel work) totalling £1.65m in FY26 alone plus prior write-downs — pattern suggests weak capital allocation on internal technology.
  • Prior-period restatements arising from Ambala acquisition accounting (professional fees, S.458 obligation), and 2024 FRC review that forced representational changes to the accounts.
  • Related-party sales to Director-connected entities (£2.3m in FY26) — disclosed and stated to be at arm's length, but material for a business of this size.
  • Founder-led company with concert-party disclosures and a former CFO removed in 2022 amid governance concerns (per prior filings).
  • Acquisition of Ambala meaningfully changed the cash-light franchise economics — corporate-store model requires more working capital and lower cash conversion.

Earnings vs. expectations

Track record is mixed. FY26 full year (Jun 2026): profit "in line with market expectations" 2026-04 trading update, 2026-06 final results. H1 FY26 (Nov 2025): "on track to deliver another year of growth in line with market expectations". FY25: revenue and EBITDA reported "ahead of expectations" 2025-07 final results. FY24: solid but with prior-year restatements. Notable miss: Aug 2022 profit warning — trading "significantly below current market forecasts" due to heatwave and input inflation 2022-08-31 trading update. Pattern: modest beats or in-line in normal conditions, single acute miss during 2022 cost-shock. Net: more beats than misses over the 5-year window, though volatility is present.

Conviction

Conviction: 3 — moderate.

  • Anchors: audited accounts with unqualified opinion; simple business model; robust asset base (£15.5m freeholds); consistent multi-year cash generation; clear disclosure of segments post-Ambala.
  • Limits: repeated intangible impairments and prior-period restatements introduce noise; Ambala synergy delivery is unproven at scale; small-cap AIM liquidity and 44m share count amplify valuation dispersion; a different methodology (DCF with higher discount rate for AIM microcap) could easily produce a wider range.
Filings consulted · 40

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-08-05Annual Report Amp Notice OF Agm2026-08-05_9704862_annual-report-amp-notice-of-agm.md0.95
  2. 2026-06-30Final Results2026-06-30_9643001_final-results.md1.00
  3. 2026-04-28Full Year Trading Update2026-04-28_9540440_full-year-trading-update.md0.85
  4. 2025-11-26Half Year Results2025-11-26_9257256_half-year-results.md0.77
  5. 2025-11-11Notice OF Half Year Results2025-11-11_9225027_notice-of-half-year-results.md0.77
  6. 2025-08-29Result OF Agm2025-08-29_9080762_result-of-agm.md0.26
  7. 2025-08-05Annual Report And Notice OF Agm2025-08-05_9027268_annual-report-and-notice-of-agm.md0.62
  8. 2025-07-24Final Results Replacement2025-07-24_8998406_final-results-replacement.md0.65
  9. 2025-07-15Final Results2025-07-15_8978968_final-results.md0.65
  10. 2025-06-26Analyst And Investor Presentations2025-06-26_8948569_analyst-and-investor-presentations.md0.46
  11. 2025-03-24Completion OF The Acquisition OF Ambala2025-03-24_8792336_completion-of-the-acquisition-of-ambala.md0.49
  12. 2025-03-12Result OF Placing2025-03-12_8775385_result-of-placing.md0.46
  13. 2025-03-12Acquisition Amp 7 2M Fundraise2025-03-12_8774556_acquisition-amp-7-2m-fundraise.md0.49
  14. 2024-11-12Half Year Results2024-11-12_8543740_half-year-results.md0.58
  15. 2024-10-10Notice OF Half Year Results2024-10-10_8477039_notice-of-half-year-results.md0.58
  16. 2024-07-30Result OF Agm2024-07-30_8338770_result-of-agm.md0.14
  17. 2024-07-04Annual Report Notice OF Agm And Board Update2024-07-04_8294061_annual-report-notice-of-agm-and-board-update.md0.43
  18. 2024-06-11Final Results2024-06-11_8252135_final-results.md0.45
  19. 2024-04-08Full Year Trading Update2024-04-08_8124520_full-year-trading-update.md0.38
  20. 2023-11-14Half Year Results2023-11-14_7878840_half-year-results.md0.41
  21. 2023-11-09Notice OF Half Year Results2023-11-09_7869872_notice-of-half-year-results.md0.41
  22. 2023-10-18Half Year Trading Update And Capital Markets Event2023-10-18_7822954_half-year-trading-update-and-capital-markets-event.md0.41
  23. 2023-08-22Result OF Agm2023-08-22_7711220_result-of-agm.md0.07
  24. 2023-08-22Agm Statement And Board Update2023-08-22_7709340_agm-statement-and-board-update.md0.10
  25. 2023-07-21Annual Report And Accounts And Notice OF Agm2023-07-21_7647802_annual-report-and-accounts-and-notice-of-agm.md0.24
  26. 2023-06-26Final Results2023-06-26_7593676_final-results.md0.25
  27. 2023-04-19Full Year Trading Update2023-04-19_7465195_full-year-trading-update.md0.21
  28. 2022-11-14Interim Results2022-11-14_7370299_interim-results.md0.23
  29. 2022-11-03Notice OF Half Year Results2022-11-03_7250654_notice-of-half-year-results.md0.23
  30. 2022-09-20Result OF Agm2022-09-20_7414126_result-of-agm.md0.07
  31. 2022-08-31Trading Update2022-08-31_7107668_trading-update.md0.21
  32. 2022-08-18Annual Report And Accounts2022-08-18_7129708_annual-report-and-accounts.md0.24
  33. 2022-06-27Full Year Results2022-06-27_7071540_full-year-results.md0.25
  34. 2022-06-20Update ON Full Year Results2022-06-20_7019557_update-on-full-year-results.md0.25
  35. 2022-04-19Trading Update2022-04-19_6983967_trading-update.md0.21
  36. 2022-03-14Management Changes And Trading Update2022-03-14_6896769_management-changes-and-trading-update.md0.21
  37. 2021-11-08Half Year Results2021-11-08_6686335_half-year-results.md0.23
  38. 2021-10-28Notice OF Half Year Results2021-10-28_6621411_notice-of-half-year-results.md0.23
  39. 2021-10-04Half Year Trading Update2021-10-04_6648395_half-year-trading-update.md0.23
  40. 2021-08-06Result OF Agm2021-08-06_6441364_result-of-agm.md0.03

This research note was authored by a large language model after reading 32 regulatory filings published between 2021-08-06 and 2026-08-05. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.